@Article{CiCC-5-3,
author = {Shihai, Gu and Hou, Chunyuan},
title = {Research and Development the Prescription of Sofosbuvir Tablets},
journal = {Communications in Computational Chemistry},
year = {2017},
volume = {5},
number = {3},
pages = {68--77},
abstract = {<p style="text-align: justify;">The prescription of sofosbuvir tablets was screened to select the best
prescription proportions. Methods: According to the prescription technology of foreign
listed tablets “sovaldi<sup>®</sup>”, experiments of diluents, disintegrating agents, binders,
lubricants and coating process were investigated, including the stability study of
self-made samples and reference tablets under the conditions of high temperature, high
humidity and illumination. We aimed to screen a reasonable prescription process.
Results: Prescription process was ultimately determined including: sofosbuvir 400 mg,
mannitol 360 mg, microcrystalline cellulose 360 mg, cross-linked sodium
carboxymethyl cellulose 60 mg, magnesium stearate 14 mg, gum arabic 6 mg, opadry
film coating powder 36 mg, and chose purified water as a binder. Conclusion: The
determined prescription process was stable, and the production process was not harsh,
it was suitable for scale-up production. The results of stability study and the dissolution
behavior in vitro were similar to those of commercial products, so the prescription is
design reasonably.</p>},
issn = {2617-8575},
doi = {https://doi.org/10.4208/cicc.2017.v5.n3.2},
url = {https://global-sci.com/article/74487/research-and-development-the-prescription-of-sofosbuvir-tablets}
}